CN106237157A - 内服外用治疗颈椎病的中药组合物 - Google Patents
内服外用治疗颈椎病的中药组合物 Download PDFInfo
- Publication number
- CN106237157A CN106237157A CN201610810142.3A CN201610810142A CN106237157A CN 106237157 A CN106237157 A CN 106237157A CN 201610810142 A CN201610810142 A CN 201610810142A CN 106237157 A CN106237157 A CN 106237157A
- Authority
- CN
- China
- Prior art keywords
- grams
- cervical spondylosis
- herba
- oral administration
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 32
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 32
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 235000007351 Eleusine Nutrition 0.000 claims abstract description 18
- 241000209215 Eleusine Species 0.000 claims abstract description 18
- 239000000919 ceramic Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 241000213006 Angelica dahurica Species 0.000 claims 1
- 244000299452 Gouania lupuloides Species 0.000 claims 1
- 235000000292 Gouania lupuloides Nutrition 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 231100000862 numbness Toxicity 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 239000011230 binding agent Substances 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000005671 spondyloarthropathy Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000019669 cervical disc degenerative disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000010037 flour treatment agent Nutrition 0.000 description 1
- 235000003132 food thickener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000008727 tongluo Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 208000029761 vertebral disease Diseases 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种内服外用治疗颈椎病的中药组合物，采用白芷、海风藤、牛筋草、倒生莲、狗骨酒和沙蒿籽等制备而成。白芷性温因其药主要效力为祛风除湿通窍止痛，配合通经络温中散寒、行气止痛的海风藤组成祛风祛寒散瘀结的药物，适宜治疗风寒侵袭，湿热瘀滞，寒湿邪气痹阻经络的颈椎疾病。沙蒿籽既可为粘结剂，又是清热解毒消肿的天然药物。本申请的药物内外兼施，更好更快地治疗颈椎疾病，无毒副作用。
Description
技术领域
本发明属于中药领域，尤其涉及一种内服外用治疗颈椎病的中药组合物。
背景技术
颈椎病又称颈椎综合症，是指颈椎间盘退行性变本身及因此而继发的一系列病理改变，如椎节失稳、松动、髓核突出或脱出；骨刺形式；韧带肥厚和继发的椎管狭窄等，刺激或压迫了邻近的神经根、脊椎、椎动脉及颈部交感神经等组织，并引起各种各样症状和体征的综合征。是中老年人的常见病和多发病，近年来有低龄化趋势。其病因病机多为肝肾不足，气血亏少，筋骨失于调养，风寒之邪骤袭，痹阻经络，湿热痰结，气血瘀滞，引起疼痛不仁等症。
发明内容
本发明的目的在于提供一种内服外用治疗颈椎疾病的中药组合物，祛风除湿通窍止痛，清热解毒散瘀止痛，可内服外用，双管齐下快速治愈颈椎疾病，无毒副作用。
为实现上述目的，本发明的技术方案是：一种内服外用治疗颈椎病的中药组合物，由以下原料和重量分组成：白芷50-140克、海风藤40-110克、牛筋草25-70克、倒生莲25-70克、狗骨酒适量、沙蒿籽适量。
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，然后放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入适量狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液。
将药渣倒在陶瓷盘内，加入适量沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
与现有技术相比，本发明所具有的优点是：
1.白芷性温因其药主要效力为祛风除湿通窍止痛，配合通经络温中散寒、行气止痛的海风藤组成祛风祛寒散瘀结的药物，适宜治疗风寒侵袭，湿热瘀滞，寒气痹阻经络的颈椎疾病。
2.牛筋草行气活血消瘀，倒生莲消炎消肿，化瘀生新，狗骨酒补肾壮骨祛风止痛，发散寒湿、助运各种药力达到治病目的。三者为辅药恰好对症治湿热瘀滞，寒湿邪气积聚，痹阻经络的颈椎疾病，是中医理论通则不痛的治疗法则。
3.沙蒿籽既可为粘结剂，又是清热解毒消肿的天然药物。本申请的药物内外兼施，更好更快地治疗颈椎疾病，无毒副作用。
具体实施方式
一种内服外用治疗颈椎病的中药组合物，由以下原料和重量分组成：白芷50-140克、海风藤40-110克、牛筋草25-70克、倒生莲25-70克、狗骨酒适量、沙蒿籽适量。
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，然后放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入适量狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液。
将药渣倒在陶瓷盘内，加入适量沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
实施例1
一种内服外用治疗颈椎病的中药组合物，由以下原料和重量分组成：白芷50克、海风藤40克、牛筋草25克、倒生莲25克、狗骨酒适量、沙蒿籽适量。
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，然后放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入适量狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液。
将药渣倒在陶瓷盘内，加入适量沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
实施例2
一种内服外用治疗颈椎病的中药组合物，由以下原料和重量分组成：白芷95克、海风藤75克、牛筋草45克、倒生莲45克、狗骨酒适量、沙蒿籽适量。
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，然后放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入适量狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液。
将药渣倒在陶瓷盘内，加入适量沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
实施例3
一种内服外用治疗颈椎病的中药组合物，由以下原料和重量分组成：白芷140克、海风藤110克、牛筋草70克、倒生莲70克、狗骨酒适量、沙蒿籽适量。
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，然后放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入适量狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液。
将药渣倒在陶瓷盘内，加入适量沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
使用方法：内服，每天2-3次，每次药液约150-200毫升，1周为1个疗程。外用，每天1-2次，1周为1个疗程，温暖敷贴颈部或疼痛患处。
应用对照组：①风寒侵袭，湿热寒夹瘀滞阻痹的颈椎病患者23人采用西药治疗，经2个疗程后，痊愈的6人，好转的7人，显效的6人，无效的4人。②风寒侵袭，湿热寒夹瘀滞阻痹的颈椎病患者23人采用实施例3内服外用药物治疗，经2个疗程后，痊愈的8人，好转的9人，显效的4人，无效的2人。头颈背部不痛，活动自如，无炎无肿，无并发症等为痊愈。病情减轻一半以上为好转。病情减轻1/5以上为显效。病情无向好方面改善为无效。
其中，部分原料的功效及作用如下：
白芷：味辛、性温，归肺、脾、胃经。功用祛风除湿，通窍止痛，消肿排脓。主治感冒头痛，眉棱骨痛，牙痛，鼻塞，鼻渊，湿胜久泻，赤白带下，痈疽疮疡。主女人漏下赤白，血闭阴肿，寒热，风头侵目泪出，长肌肤，润泽，可作面脂。
海风藤：味苦、性湿、入心肾二经，祛风湿、通经络、理气止痛，主治风寒湿痹、肢节疼痛、筋脉拘挛、脘腹冷痛、水肿。行经络和血脉、宽中理气、下湿除风、理腰脚气，治疝、安胎，宣痹、化湿、通络舒筋、温中散寒、行气止痛、利水消肿、治腰膝疼痛、关节疼痛。
牛筋草：又名千金草、穇子草等。味甘、淡，凉，入肝经。功用清热解毒，利湿，凉血散瘀。主治伤暑发热，小儿惊风，乙脑，流脑，黄疸，淋证，小便不利，痢疾，便血，疮疡肿痛，荨麻疹，跌打损伤。活血补气，行血长力，强筋骨，治遗精，驱风利湿，散瘀止血。
倒生莲：味辛、微苦，性凉，归肝、肺、膀胱经。清热除湿，化瘀止血，主治咳嗽痰多，风湿痹痛，肠炎痢疾，跌打损伤等。有消炎、消肿、活血、驱风、清热、化瘀生新，续筋通关节，疗风湿的作用。
狗骨酒：狗骨甘、咸、温，补肾壮骨、祛风止痛、止血止痢、敛疮生肌，主治风湿关节疼痛、腰腿无力、四肢麻木、冷风骨痛、崩漏带下、久痢不止、外伤出血、小儿解颅、痈肿疮痿、冻疮。能够补虚壮阳、生肌长肉。其酒能串通络脉四肢，辛温肌体、发散寒湿、助运各种药力达到治病目的。
沙蒿籽：又名黑沙蒿子。是生长在内蒙古沙漠地区的黑沙蒿植物的沙蒿籽。味辛、苦，性微温，无毒。经长期应用经验，其沙蒿籽也有祛风除湿，清热解毒消肿的功效。沙蒿籽的主要成分由D-葡萄糖、D-甘露醇、D-半乳糖、L-阿拉伯糖和木糖组成的一种具有交联结构的多糖类物质。粘度大（1%溶液达900Pa.s）为明胶的1800倍，不溶于水，但可均匀分散于水，吸水数十倍后溶胀成蛋清样胶体。可作食品增稠剂、保水剂、稳定剂和面团调节剂。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种内服外用治疗颈椎病的中药组合物，其特征在于，由以下原料和重量分组成：白芷50-140克、海风藤40-110克、牛筋草25-70克、倒生莲25-70克、狗骨酒适量、沙蒿籽适量，
将白芷、海风藤、牛筋草和倒生莲筛选、净化、粉碎，放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬20-30分钟，离火，晾凉至微温，加入狗骨酒拌匀，倒滤出汤汁，即成为治疗颈椎病的内服药液，
将药渣倒在陶瓷盘内，加入沙蒿籽拌匀，即成为治疗颈椎病的外用药物。
2.根据权利要求1所述一种内服外用治疗颈椎病的中药组合物，其特征在于，由以下原料和重量分组成：白芷50克、海风藤40克、牛筋草25克、倒生莲25克、狗骨酒适量、沙蒿籽适量。
3.根据权利要求1所述一种内服外用治疗颈椎病的中药组合物，其特征在于，由以下原料和重量分组成：白芷95克、海风藤75克、牛筋草45克、倒生莲45克、狗骨酒适量、沙蒿籽适量。
4.根据权利要求1所述一种内服外用治疗颈椎病的中药组合物，其特征在于，由以下原料和重量分组成：白芷140克、海风藤110克、牛筋草70克、倒生莲70克、狗骨酒适量、沙蒿籽适量。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610810142.3A CN106237157A (zh) | 2016-09-08 | 2016-09-08 | 内服外用治疗颈椎病的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610810142.3A CN106237157A (zh) | 2016-09-08 | 2016-09-08 | 内服外用治疗颈椎病的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106237157A true CN106237157A (zh) | 2016-12-21 |
Family
ID=57600043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610810142.3A Withdrawn CN106237157A (zh) | 2016-09-08 | 2016-09-08 | 内服外用治疗颈椎病的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106237157A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104510803A (zh) * | 2015-01-09 | 2015-04-15 | 佛山市顺德区宝铜金属科技有限公司 | 用于肾阳虚痹证的中成药 |
-
2016
- 2016-09-08 CN CN201610810142.3A patent/CN106237157A/zh not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104510803A (zh) * | 2015-01-09 | 2015-04-15 | 佛山市顺德区宝铜金属科技有限公司 | 用于肾阳虚痹证的中成药 |
Non-Patent Citations (1)
| Title |
|---|
| 王前中等: "重用白芷治疗颈椎病", 《中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1285196A (zh) | 风寒湿痹证蠲痹膏 | |
| CN105833193A (zh) | 一种治疗风湿骨病膏药 | |
| CN103191377A (zh) | 一种治疗风湿骨病膏药 | |
| CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
| CN101954053B (zh) | 一种中药贴剂及其制备方法 | |
| CN108653532A (zh) | 一种治疗骨病的中药组合物 | |
| CN112807411A (zh) | 具有舒筋活络功能的外用中药组合物、热敷药包及外用中药制剂 | |
| CN101700388A (zh) | 一种治疗外伤型颈椎病的中药 | |
| CN101406559A (zh) | 一种熏疗寒痹的药物 | |
| CN106237157A (zh) | 内服外用治疗颈椎病的中药组合物 | |
| CN103990067B (zh) | 治疗腰椎间盘突出的外用药物及其制备方法 | |
| CN106924700A (zh) | 一种颈椎热疗中药包及制备方法 | |
| CN101954043A (zh) | 一种治疗骨质增生的药物及其制备方法 | |
| CN106266271A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN100388946C (zh) | 一种治疗骨科疾病的药膏及其制备方法 | |
| CN104758798A (zh) | 一种治疗骨关节病的中药组合物及其制备方法 | |
| CN104825939A (zh) | 一种治疗腰肌劳损的中药制剂 | |
| CN106109842A (zh) | 用于治疗腰椎间盘突出症的中药 | |
| CN102579732B (zh) | 一种治疗股骨头坏死的药膏及制备方法 | |
| CN106236950A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN101953932A (zh) | 一种熏疗寒痹的药物 | |
| CN106110087A (zh) | 一种治疗腰椎间盘突出症的中药 | |
| CN106138824A (zh) | 一种治疗鹤膝风的药物 | |
| CN106109713A (zh) | 一种内服外用治疗鹤膝风药物及制备方法 | |
| CN106309697A (zh) | 治疗腰椎间盘突出症的中药及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161221 |